|4May 1, 6:10 PM ET

DeLuca Richard R. 4

4 · Merck & Co., Inc. · Filed May 1, 2025

Insider Transaction Report

Form 4
Period: 2025-04-29
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Transactions
  • Award

    Restricted Stock Unit

    2025-04-29+7,5557,555 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (7,555 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-04-29+34,39034,390 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28Common Stock (34,390 underlying)
Holdings
  • Common Stock

    180,729.7
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    1,281.196
Footnotes (5)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Includes shares acquired and dividends earned through April 7, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F5]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT